The GHK-Cu serum to start with is The Ordinary Multi-Peptide + Copper Peptides 1%, because its maker publishes the peptide, the percentage and the pH.
- Randomised trials are few and mixed, and the one on laser-treated faces found no objective gain.
- Copper peptides barely cross intact skin, so delivery is the real variable.
- Serums address skin quality, not lost facial fat.

By the time you are comparing bottles, the decision to try a GHK-Cu serum is usually already made. What is left is the question people put to each other in the forums: which of these is doing anything, and which is a nice label on a scam. Search and the same seven or eight products come back in roughly the same order, on pages that mostly lean on the same review paper. What matters is who wrote that paper, and what the controlled trials of the ingredient found when they looked. Both facts change how you build a shortlist.
There is a second problem that belongs specifically to people losing weight fast on a GLP-1. The hollowing people call Ozempic face is mostly deep facial fat leaving, and nothing applied to the surface puts fat back. Skin quality is a separate and smaller part of what changed. A serum can plausibly help with the second thing while doing nothing at all about the first, and a buying guide that does not say so is selling the wrong expectation. If the ingredient itself is still an open question, the GHK-Cu explainer covers the mechanism and the regulatory status before any of this matters.
Table of Contents
Disclosure: This article contains affiliate links. If you purchase through these links I may earn a small commission at no extra cost to you.
What Separates One Copper Peptide Serum From Another?
What separates one bottle from the next is concentration, the delivery system, packaging that keeps copper away from light and air, and whether the formula tells you a pH. Price tracks none of them. Two serums with identical marketing can differ on all four, and the ingredient panel is where you find out which.
Ranking branded products by name runs into a problem. Brands are not required to disclose how much copper tripeptide-1 a formula holds, and most do not, so a ranked list is usually a ranking of marketing copy. Here is what each class buys and where each one fails.
| Formulation class | What you are buying | Where it is strong | What to check first |
|---|---|---|---|
| Single peptide, disclosed percentage | Copper tripeptide-1 named on the label with a number beside it, few other actives | The easiest class to judge before buying, and the easiest to isolate if your skin reacts | Whether the percentage describes the peptide or a proprietary blend it sits inside |
| Multi-peptide blend | Copper peptide plus signal peptides, often with niacinamide or hyaluronic acid | One step instead of three, and usually the lowest cost per millilitre | Whether copper content is disclosed anywhere. In this class it usually is not |
| Encapsulated or liposomal | The peptide carried inside a lipid vesicle intended to improve uptake | Aimed at the weakest point in the whole category, which is getting the molecule in | Whether the brand names the carrier system or just uses the word advanced |
| High-strength vendor lines | Much higher stated copper concentrations, usually sold by peptide suppliers | Nothing published supports going high, so there is no strength here to name | Irritation risk climbs with concentration and the copper claim is rarely verified |
What Does the Evidence for Topical GHK-Cu Show?
Less than the category implies, and the shape of the gap matters more than the size of it. Across the GLP-1 and peptide forums the argument splits the same way every time: someone reports that their skin looks better, someone else answers that nothing has been proven and the studies have not been done. Both are reading the same evidence base, and it is thinner than either side assumes. Much of the enthusiastic writing about copper peptides online leans on one 2015 review in BioMed Research International, which describes GHK stimulating collagen synthesis, attracting repair cells and improving elasticity and firmness in cosmetic use. The paper is real and the mechanistic work behind it is real.
The affiliation printed on that paper is Skin Biology, a company that develops and sells copper peptide skincare. That does not make the review wrong. It does mean the single most-cited source in the category was written by people with a commercial interest in the answer.
One randomised trial on faces produced a null result. A randomised controlled trial, where chance decides who gets the product so the two groups can be compared fairly, published in Archives of Facial Plastic Surgery in 2006 put a GHK-Cu skincare regimen against a regimen without it after carbon dioxide laser resurfacing. Thirteen patients completed it. Computer analysis and blinded evaluators found no significant difference in how fast redness resolved, and no significant difference in wrinkles or overall skin quality at twelve weeks. The one measure that did separate was patient satisfaction, which was higher in the copper peptide group.
Read that honestly in both directions. Thirteen people is a small trial, and post-laser skin is not the same setting as daily cosmetic use on a face that is thinning from weight loss, so this is not a clean test of the thing being sold. What it found was that people liked using it more than the measurements could justify.
The randomised trials on wounds disagree with each other. One in Wound Repair and Regeneration in 1994 found a GHK-Cu gel closed more of each diabetic foot ulcer than an inactive gel: a median 98.5% of the wound area against 60.8%. One in the Journal of Vascular Surgery in 1992 found a 0.4% copper tripeptide cream did no better than placebo on venous leg ulcers in 86 patients. An open wound has no barrier to cross, so neither result says much about a serum on intact skin.
Can a Copper Peptide Reach the Layer It Needs to Reach?
This is the question the category is quietest about. GHK-Cu is a small, water-loving molecule and the outer skin barrier is built to keep exactly that kind of molecule out. That has been measured. A 2015 permeation study in Pharmaceutical Research tracked how much copper peptide crossed human skin over nine hours. Through skin pre-treated with a microneedle array, 134 nanomoles of peptide and 705 nanomoles of copper came through. Through intact skin, the authors recorded almost none.
That was a laboratory skin model, and a serum is not the same vehicle as the solution used in that experiment. The direction still holds, and it reorders your buying criteria. Concentration is the number brands like to compete on, and it is the second question. How the formula proposes to get the peptide past the barrier is the first one.
Nothing on a shelf solves that fully. Encapsulation is the most common attempt, and the honest description of it is a reasonable idea with thin published support. The free version is application technique: onto clean, still-damp skin, before anything occlusive. If you put it on fourth, over a moisturiser, you have paid for a delivery system and then blocked it.
What Should a GHK-Cu Serum Label Tell You?
A label should tell you the peptide, the percentage, the packaging and the pH, and one that carries all four is already in the minority. The peptide named plainly as copper tripeptide-1 or GHK-Cu on the ingredient list, rather than buried inside a trademarked complex whose composition is never stated. A percentage. Packaging that is opaque and air-restricted, because light and oxygen degrade copper peptide solutions. And a stated pH, or guidance on what to keep it away from. In the peptide world the answer to an unregulated market is an independent lab result before anyone trusts a vial. There is no equivalent on a cosmetic shelf. What the brand chooses to print is what you get.
Formulators generally keep copper peptides away from low-pH direct acids, particularly high-dose vitamin C, on the reasoning that the copper complex is unstable in that environment. That advice is close to universal in formulation guidance and it is not settled in published work, so treat it as a sensible default. Using them in separate sessions costs you nothing and removes the question.
Price is a poor guide to whether a GHK-Cu serum is well made. The same nominal ingredient sells across a very wide range, and the cheap end includes formulas that disclose more than the expensive end does. The four checks cost nothing to run, and they are the whole of what you can know before the bottle arrives.
What Disqualifies a Copper Peptide Serum?
Each of these is enough on its own to put a product back on the shelf.
- A clear bottle, or a wide-mouth jar. Light and repeated air exposure work against the ingredient, and packaging is the cheapest signal of whether a brand knows that.
- The phrase copper peptide complex with no percentage stated anywhere, including the brand’s own product page.
- A formula that also runs a high-dose direct acid in the same bottle, which puts the stability question inside the product rather than inside your routine.
- Structural claims. The FDA treats a product meant to remove wrinkles or raise the skin’s own collagen as a drug, so lifting, reversing and rebuilding on a serum label tell you how that brand treats evidence generally.
- Research-use-only vials sold by peptide suppliers for facial use. In peptide circles the not-for-human-consumption wording is read as the thing that keeps the supply legal; it is not a quality statement about what is in the vial. Those are not cosmetics, they carry no cosmetic safety assessment, and the wider problem with that supply route is covered in the guide to which peptides are legal and which are research-stage. Injecting GHK-Cu has no published human safety data. The clinical picture so far comes from press reports: a clinician told NPR in September 2026 that he sees infections and raised liver enzymes and copper in people who injected vials bought online.
How I chose: I ran that screen, and the four label checks above, against six copper serums that come up most in search results and forum recommendations in October 2026. None passed every check. Four fell short on the basics, from no percentage anywhere to a clear bottle or tightening claims on the label. The other two, The Ordinary and NIOD’s Copper Amino Isolate Serum, both state 1% copper peptides and come in an amber dropper bottle, which keeps light out but lets air in each time you open it.
The Ordinary Multi-Peptide + Copper Peptides 1% is the default because it carries the same 1% and states a pH of 6 to 7 at about a quarter of NIOD’s price per millilitre, and The Ordinary lists what not to combine it with, including direct acids, vitamin C and retinoids. If your protein intake and resistance training are not yet in place, start there instead: they protect the muscle the skin lies over, and protein supplies the amino acids the body makes collagen from. Do not buy one at all if your real complaint is the hollowing under the cheekbones, which is lost fat that nothing applied to the skin returns.
The serum to start with
The Ordinary Multi-Peptide + Copper Peptides 1%
The Ordinary states the 1% and a pH of 6 to 7, so you know what you are buying before the bottle arrives. At $32 for 30 ml it is a cheap way to find out whether a copper peptide does anything for your skin.
The catch: the amber dropper keeps out light, though air gets in each time you open it, and The Ordinary says to keep it away from direct acids, vitamin C and retinoids. It does nothing for lost facial fat.
See it at SephoraAffiliate link. If you buy, I may earn a small commission at no extra cost to you.
How Long Before Anything Shows?
Twelve weeks is a fair trial and a fair stopping point. I found no study that sets a timeline for daily cosmetic use of a copper peptide serum, so twelve weeks is borrowed from the 2006 trial above, which took its final measurements at that point.
Judging your own result is harder here than in a normal skincare trial, and this is where the GLP-1 context bites. Facial appearance is already moving week to week from weight loss itself, so your own before-and-after photo cannot separate what the serum did from what the medication did. Fixed lighting, the same time of day and the same angle at least narrow it. If twelve weeks of consistent use produce nothing you can see under those conditions, that is an answer.
What a Copper Peptide Serum Cannot Fix
The hollow look under the cheekbones is deep facial fat that has gone, and no topical returns it. Restoring volume is a clinical conversation about fillers, biostimulators or simply letting weight stabilise, and it belongs with a practitioner who can look at your face.
The basics are unglamorous and mostly free, and no study has tested any of them against a serum. Enough protein while eating far less, since the body makes collagen from the amino acids in it, according to the Cleveland Clinic’s patient guide to collagen. Resistance training, which a joint advisory from four US nutrition and obesity societies calls well established for preserving muscle during weight loss. A slower rate of loss, which a commentary in the Journal of Cosmetic Dermatology names as one limit on how far skin can shrink back; that is a conversation for your prescriber.
Those levers are covered in the guide to loose skin on a GLP-1, and the maintenance-phase version sits in the peptide therapy after GLP-1 article.
A copper peptide serum can sit alongside those basics rather than replace them. It is plausible, cheap relative to the alternatives, and the evidence for it on skin is thin. If you buy one, run the four label checks first, then keep the protein and the training going while you find out whether it does anything for you.
When a trial reads out, a compounder pulls one of these compounds, or the FDA changes its position, you’ll hear it from me along with what it means for you. The change and its context arrive in one email.
Unsubscribe anytime.
References
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International, 2015. doi.org/10.1155/2015/648108
- Miller TR, et al. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Archives of Facial Plastic Surgery, 2006. doi.org/10.1001/archfaci.8.4.252
- Mulder GD, et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair and Regeneration, 1994. doi.org/10.1046/j.1524-475X.1994.20406.x
- Bishop JB, et al. A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. Journal of Vascular Surgery, 1992. doi.org/10.1067/mva.1992.37086
- Li H, et al. Microneedle-Mediated Delivery of Copper Peptide Through Skin. Pharmaceutical Research, 2015. doi.org/10.1007/s11095-015-1652-z
- U.S. Food and Drug Administration. Wrinkle Treatments and Other Anti-aging Products. Content current as of 25 February 2022. fda.gov
- Stone W. The copper peptide trend has gone from creams to injections, ahead of the science. NPR, 7 September 2026. npr.org
- Cleveland Clinic. Collagen: What It Is, Types, Function and Benefits. Patient health guide. my.clevelandclinic.org
- Mozaffarian D, et al. Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. American Journal of Lifestyle Medicine. 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12125019
- Haykal D, Hersant B, Cartier H, Meningaud JP. The Role of GLP-1 Agonists in Esthetic Medicine: Exploring the Impact of Semaglutide on Body Contouring and Skin Health. Journal of Cosmetic Dermatology. 2025;24(2):e16716. Commentary; the authors report honoraria and research support from aesthetic-treatment companies. pmc.ncbi.nlm.nih.gov/articles/PMC11845967
